In keeping with the hypothesized importance of primed activation of JAK-STAT genes in M1 resistance, inhibition of JAK1/2 by Ruxolitinib treatment during the polarization phase (prior to infection) resulted in the increased susceptibility of M1 macrophages to Salmonella. Here, JAK1 is linked to infection.